Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors
- PMID: 1347569
Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors
Abstract
We determined the affinities of clozapine and 21 other typical and atypical antipsychotic agents for the cloned 5-hydroxytryptamine-1C (5-HT1C) receptor. For these studies, 5-HT1C receptors were transiently expressed in COS-7 cells using the vector pSVK3-5HT1C. We discovered that clozapine and several other putative typical and atypical antipsychotic agents (loxapine greater than tiosperone greater than SCH23390 greater than fluperlapine greater than rilapine greater than chlorpromazine) had relatively high affinities (7-30 nM) for the cloned 5-HT1C receptor. Other antipsychotic agents (risperidone greater than tenilapine greater than mesoridazine greater than thioridazine greater than cis-fluphenthixol) had intermediate affinities (30-100 nM), whereas many other antipsychotics (fluphenazine greater than spiperone greater than amperozide greater than melperone greater than thiothixene greater than haloperidol, metoclopramide, pimozide, domperidone, sulpiride) had low affinities (greater than 500 nM) for the cloned 5-HT1C receptor. The results indicate that although several putative atypical antipsychotic agents have high affinities for the cloned rat 5-HT1C receptor, the spectrum of drug binding does not correlate with the atypical nature of these compounds.
Similar articles
-
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. J Pharmacol Exp Ther. 1994. PMID: 7908055
-
Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.J Pharmacol Exp Ther. 2001 Oct;299(1):83-9. J Pharmacol Exp Ther. 2001. PMID: 11561066
-
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.J Pharmacol Exp Ther. 2000 Oct;295(1):226-32. J Pharmacol Exp Ther. 2000. PMID: 10991983
-
Atypical antipsychotics: mechanism of action.Can J Psychiatry. 2002 Feb;47(1):27-38. Can J Psychiatry. 2002. PMID: 11873706 Review.
-
The importance of serotonin-dopamine interactions in the action of clozapine.Br J Psychiatry Suppl. 1992 May;(17):22-9. Br J Psychiatry Suppl. 1992. PMID: 1358125 Review.
Cited by
-
ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.Psychopharmacology (Berl). 2005 Dec;183(2):144-53. doi: 10.1007/s00213-005-0170-9. Epub 2005 Nov 9. Psychopharmacology (Berl). 2005. PMID: 16220333
-
Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.Psychopharmacology (Berl). 2011 Jun;215(3):581-93. doi: 10.1007/s00213-011-2207-6. Epub 2011 Feb 22. Psychopharmacology (Berl). 2011. PMID: 21340474
-
Molecular interactions between general anesthetics and the 5HT2B receptor.J Biomol Struct Dyn. 2015;33(1):211-8. doi: 10.1080/07391102.2013.869483. Epub 2013 Dec 23. J Biomol Struct Dyn. 2015. PMID: 24365264 Free PMC article.
-
DREADDs for Neuroscientists.Neuron. 2016 Feb 17;89(4):683-94. doi: 10.1016/j.neuron.2016.01.040. Neuron. 2016. PMID: 26889809 Free PMC article. Review.
-
Role of serotonin in central dopamine dysfunction.CNS Neurosci Ther. 2010 Jun;16(3):179-94. doi: 10.1111/j.1755-5949.2010.00135.x. CNS Neurosci Ther. 2010. PMID: 20557570 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Chemical Information